Canada Pension Plan Investment Board’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
Other funds holding RVNC
AAM
MF
TCM
WIC
Canada Pension Plan Investment Board's RVNC Position: Q3 2024 in Review
Canada Pension Plan Investment Board sold out of Revance Therapeutics, Inc. (RVNC) in Q3 2024, closing a stake of 7,700 shares — an estimated $19.8K sold.
Canada Pension Plan Investment Board first reported a position in RVNC in Q3 2015 and held it in 17 quarters. The position peaked at $20.8M in Q4 2015. 201 funds tracked by Wall St. Rank hold RVNC as of Q3 2024.
- Canada Pension Plan Investment Board reported no remaining Revance Therapeutics, Inc. position as of Q3 2024 after selling out during the quarter.
- Canada Pension Plan Investment Board sold 7,700 Revance Therapeutics, Inc. shares in Q3 2024, an estimated $19.8K.
- Canada Pension Plan Investment Board first reported a position in Revance Therapeutics, Inc. in Q3 2015 and held it in 17 quarters.
- Canada Pension Plan Investment Board's Revance Therapeutics, Inc. position peaked at $20.8M in Q4 2015.
- 201 funds tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q3 2024.
Based on Canada Pension Plan Investment Board's 13F filing for Q3 2024, filed 14 Nov 2024.